Table 2.
Exposure and risk characterization to AFM1 among males and females infants (0–12 months) through IPF intake at different ages calculated through EDI, HQ and MOE, respectively.
| Age | IPF Consumption | Average Weight * (kg) | EDI (ng/kg b.w./Day) | HQ | MOE | ||||
|---|---|---|---|---|---|---|---|---|---|
| Ml/Day | Male | Female | Male | Female | Male | Female | Male | Female | |
| 0–1 weeks | 420 | 3.8 | 3.7 | 0.39 | 0.40 | 1.93 | 1.99 | 1473.47 | 1434.69 |
| 1–4 weeks | 540 | 4.3 | 4.5 | 0.44 | 0.42 | 2.20 | 2.10 | 1296.83 | 1357.14 |
| 2–8 weeks | 720 | 5.3 | 5.2 | 0.48 | 0.48 | 2.38 | 2.42 | 1198.81 | 1176.19 |
| 2–3 months | 750 | 6.5 | 5.9 | 0.40 | 0.44 | 2.02 | 2.22 | 1411.43 | 1281.14 |
| 3–5 months | 900 | 7.5 | 6.9 | 0.42 | 0.46 | 2.10 | 2.28 | 1357.14 | 1248.57 |
| 5–6 months | 900 | 8.5 | 7.7 | 0.37 | 0.41 | 1.85 | 2.05 | 1538.10 | 1393.33 |
| 6–8 months | 945 | 9.3 | 8.4 | 0.78 | 0.87 | 3.91 | 4.33 | 728.51 | 658.01 |
| 8–10 months | 945 | 10.2 | 9.3 | 0.71 | 0.78 | 3.57 | 3.91 | 799.01 | 728.51 |
| 10–12 months | 945 | 10.9 | 10 | 0.67 | 0.73 | 3.34 | 3.64 | 853.84 | 783.34 |
| Age Categories | |||||||||
| 0–6 months | 705 | 5.98 | 5.6 | 0.67 | 0.71 | 3.37 | 3.57 | 169.15 | 159.72 |
| 6–12 months | 945 | 10.13 | 9.23 | 0.53 | 0.59 | 2.67 | 2.93 | 213.71 | 194.73 |
| Average | 785 | 7.4 | 6.84 | 0.61 | 0.66 | 3.05 | 3.28 | 187.03 | 173.77 * |
* https://www.cdc.gov/growthcharts/html_charts/wtageinf.htm (accesed on 12 March 2022). It was based on 75 percentile.